Pharmaceuticals

In-Depth Biomarkers Market Report: Business Trends, Growth Factors, and Forecast to 2029

August 21, 2025 by Marketing Posting

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only._x000D_

_x000D_

#What Does the Forecast Indicate for the Biomarkers Market From 2025 to 2029?#_x000D_

In the recent past, the size of the biomarkers market has experienced swift expansion. It is projected to escalate from a valuation of $68.77 billion in 2024 to a staggering $77.42 billion in 2025, which means a compound annual growth rate (CAGR) of 12.6%. Key factors that have driven this growth during the historical period include developments in genomics and proteomics technologies, a rising prevalence of chronic diseases, a greater focus on personalized medicine, increased demand for companion diagnostics and a broadening of their uses in the domain of drug development._x000D_

_x000D_

In the coming years, the biomarkers market is projected to experience substantial growth, expanding to an estimated $131.78 billion by 2029 with a compound annual growth rate (CAGR) of 14.2%. This expansion during the predicted period is due to an increasing emphasis on early disease diagnosis and prevention, the broadening use of biomarkers in oncology and immunotherapy, escalating investments in precision medicine programs, the emergence of liquid biopsy as a non-invasive technique for biomarker identification, and a growing preference for biomarkers in drug discovery and development. Key trends expected throughout this forecast period involve the creation of multi-biomarker panels, the rise of exosome-based biomarkers, the utilization of point-of-care biomarker testing, the integration of real-world data into biomarker research, and the exploration of microbiome-based biomarkers._x000D_

_x000D_

#Download The Free Sample Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=6485&type=smp_x000D_

_x000D_

#What Elements Are Contributing To Growth In The Biomarkers Market?#_x000D_

The escalating incidence of heart diseases is predicted to fuel the expansion of the biomarkers market in the projected timeframe. Biomarkers’ use in treating heart disease patients has seen an exceptional rise in recent times. Natriuretic peptides, as of now, are the most prevalent biomarker, assisting in the identification of individuals suffering from heart failure. Other biomarkers, like circulating ones with high sensitivity C-reactive protein, are employed for heart failure diagnoses. Heart ailments are among the primary death causes for most racial and ethnic groups in the United States, thus pushing the demand for biomarkers. As reported by the American College of Cardiology, a US-based non-profit medical group, in August 2022, it is estimated that all four cardiovascular risk elements will augment between 2025 and 2060 in the United States. Diabetes is projected to see the largest percentage increase with a surge of 39.3% to 55 million cases, followed by dyslipidemia (27.6% to 126 million), hypertension (25.1% to 162 million), and obesity (18.3% to 126 million). The study further observed that stroke (33.8% to 15 million) and heart failure (33.4% to 13 million) are predicted to feel the most significant increases in cardiovascular disease rates. Next in line, ischemic heart disease (30. 7% to 29 million) and heart attack (16.9% to 16 million) follow. This incline in heart diseases and corresponding mortalities will result in the growth surge for the biomarkers._x000D_

_x000D_

#Which Segments Are Detailed In The Global Biomarkers Market Report?#_x000D_

The biomarkers market covered in this report is segmented – _x000D_

_x000D_

1) By Technology: Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers_x000D_

2) By Disease: Neurological Diseases, Cancer, Immunological Diseases, Cardiovascular Diseases, Other Diseases_x000D_

3) By Type: Biomarker Of Exposure, Biomarker Of Diseases_x000D_

4) By Audiences: Pharmaceutical Companies, Government And Private Research Institutes, Academic Institutes, Medical Device Manufacturing Companies_x000D_

_x000D_

Subsegments:_x000D_

1) By Safety Biomarkers: Toxicity Biomarkers, Pharmacokinetic Biomarkers, Adverse Effect Biomarkers _x000D_

2) By Efficacy Biomarkers: Pharmacodynamic Biomarkers, Disease Progression Biomarkers, Treatment Response Biomarkers_x000D_

3) By Validation Biomarkers: Analytical Validation Biomarkers, Clinical Validation Biomarkers, Qualification Biomarkers_x000D_

_x000D_

#Which Emerging Trends And Strategic Shifts Are Shaping The Biomarkers Market?#_x000D_

Leading organizations in the biomarker market are concentrating on formulating unique solutions like a novel biological marker, through joint research efforts, technological amalgamation, and strong clinical verification. A novel biological marker is a newly recognized sign that shows biological activities and helps in identifying or tracking illnesses. It can represent a molecule, gene, or cellular attribute with prospective applications in personalized medicine. For example, Genialis, a computational precision medicine firm from the US, launched an unprecedented biomarker in September 2024. This first-of-its-kind biomarker augments predictive precision for how patients react to KRAS inhibitors, facilitating tailor-made treatment plans, and enhancing clinical results. Its wide-ranging usage across multiple cancer forms accelerates effective drug creation and refines patient choice for targeted therapies._x000D_

_x000D_

#Who Are The Key Contributors To Growth In The Biomarkers Market?#_x000D_

Major companies operating in the biomarkers market include Enzo Biochem Inc, Bio-Rad Laboratories Inc., Merck KGaA, PerkinElmer Inc., QIAGEN N. V., Adaptive Biotechnologies Corp., Agilent Technologies Inc., Biocrates Life Sciences AG, BioFire Diagnostics LLC, BioReference Laboratories Inc., Bio-Techne Corporation, Cepheid Inc., Eurofins Scientific SE, Exact Sciences Corporation, Foundation Medicine Inc., Genomic Health Inc., GenScript Biotech Corporation, Guardant Health Inc., Illumina Inc., Invitae Corporation, Laboratory Corporation of America Holdings, Luminex Corporation, Metabolon Inc., Myriad Genetics Inc., Natera Inc., Pacific Biosciences of California Inc., Quest Diagnostics Incorporated, Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Veracyte Inc. _x000D_

_x000D_

#Get The Full Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report_x000D_

_x000D_

#Which Region Is Projected To Lead The Biomarkers Market By 2025?#_x000D_

North America was the largest region in the biomarkers market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_

_x000D_

#Request For A Customized Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=6485&type=smp_x000D_

_x000D_

#About The Business Research Company:#_x000D_

_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 7882 955267 & +91 8897263534_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_